A biotech management recruiter commented:

  MA will pull away with the lead soon from Bay Area
  based on cost of living. I have senior management
  members tell me daily that they'll move anywhere
  BUT Bay Area. You'll pay $3.2m for 3/4 BR in Palo
  Alto. South Bay and North Bay aren't too much better.

Oklahoma City has a small but strong Biotech and medical device scene ($6.7B Revenue, $2.2B salaries for a workforce of 51,000). Even then most companies in OKC raise money in SF & Boston and either have an office there or move back and forth. Which is pointed out in the section on satellite offices. The satellite office trend I don't see stopping given how cheap flights are and how fast communications have become between coasts.

Uh, San Diego conspicuously not on the list here?

> These data are striking.

The use of 'data' to mean 'plural of datum' continues to fall out of favor in modern usage. Encountering it in a Saturday-morning browse was a note of angelic harmony to start the day.

Wow this article is pretty condescending towards the biotech scene in Europe...

I'm going to go out on a limb here and say, maybe there are fewer biotech startups in Europe because profiting off of people's illnesses is generally frowned upon?

My guess is progress in that area falls more into the realm of government grants, with maybe the exception of classical pharmaceuticals (there are plenty of old companies like Bayer).

Biotech is not my field so I'd be interested in hearing other people's opinions.